Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | ABCD4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ABHD15 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ABHD17A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | AC002310.13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | AC003002.6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | AC003006.7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AC005943.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |